India  

United States: Mintz IRA Update — Legal Challenges To The Medicare Drug Price Negotiation Program Continue - Mintz

Mondaq Monday, 4 March 2024
The IRA's Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program"), which aims to lower drug prices by enabling the federal government to negotiate prices...
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

United States: Mintz IRA Update — Demystifying The IRA's Small Biotech Exception - Mintz

On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA's Medicare Drug Price...
Mondaq

United States: Mintz IRA Update — The IRA In 2024: The Medicare Drug Price Negotiation Program In Full Swing And Other Developments - Mintz

Our team's preparation for the year includes a review of the anticipated impact of the IRA on the health care industry in 2024.
Mondaq